Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?

Allal, Abdelkarim Said; De Pree, Christian; Dulguerov, Pavel; Bieri, Sabine; Maire, Daphne Isabel; Kurtz, John

doi:10.1016/S0360-3016(99)00138-8

Scientific article

Open access

English

Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?

ContributorsAllal, Abdelkarim Said; De Pree, Christian; Dulguerov, Pavel; Bieri, Sabine; Maire, Daphne Isabel; Kurtz, John

Published inInternational journal of radiation oncology, biology, physics, vol. 45, no. 1, p. 41-45

Publication date1999

Abstract

To assess the impact of treatment interruption on the potential gain in locoregional control obtained with accelerated radiotherapy (RT) compared with conventionally fractionated RT in patients with oropharyngeal carcinomas.

Keywords

Adult
Aged
Aged, 80 and over
Analysis of Variance
Dose Fractionation
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Staging
Oropharyngeal Neoplasms/mortality/radiotherapy
Prognosis
Proportional Hazards Models
Retrospective Studies

Affiliation

Research group

Groupe Dulguerov Pavel (ORL et chirurgie cervico-faciale) (145)

Citation (ISO format)

ALLAL, Abdelkarim Said et al. Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas? In: International journal of radiation oncology, biology, physics, 1999, vol. 45, n° 1, p. 41–45. doi: 10.1016/S0360-3016(99)00138-8

Article (Published version)

Identifiers

PID : unige:33174
DOI : 10.1016/S0360-3016(99)00138-8
PMID : 10477004

ISSN of the journal0360-3016

509views

381downloads

Creation10/28/2013 9:08:00 PM

First validation10/28/2013 9:08:00 PM

Update time03/14/2023 8:50:31 PM

Status update03/14/2023 8:50:31 PM

Last indexation01/16/2024 8:51:33 AM

Archive ouverte UNIGE

Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?

To assess the impact of treatment interruption on the potential gain in locoregional control obtained with accelerated radiotherapy (RT) compared with conventionally fractionated RT in patients with oropharyngeal carcinomas.

Technical informations